Recent Additions
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
This page includes the documents that were newly added to the repository within the last 30 days.
41 - 60 of 1261 Results
View:
Sort By:
Refine Results
All Collections
Small Close Icon

Sort By

Next ›
  • Confirmed COVID-19 cases and deaths in US correctional and detention facilities by state
    Filetype[PDF - 285.69 KB]
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    January 14, 2021
    Series:
    CDC COVID Data Tracker
    Description:
    Last updated: 14-Jan-21
    File Type:
    Filetype[PDF - 285.69 KB]
    Added:
    01/15/2021
  • Confirmed COVID-19 cases in US correctional and detention facilities by state
    Filetype[PDF - 285.47 KB]
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    January 14, 2021
    Series:
    CDC COVID Data Tracker
    Description:
    Last updated: 14-Jan-21
    File Type:
    Filetype[PDF - 285.47 KB]
    Added:
    01/15/2021
  • Confirmed COVID-19 deaths in US correctional and detention facilities by state
    Filetype[PDF - 288.57 KB]
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    January 14, 2021
    Series:
    CDC COVID Data Tracker
    Description:
    Last updated: 14-Jan-21
    File Type:
    Filetype[PDF - 288.57 KB]
    Added:
    01/15/2021
  • New COVID-19 variants
    Filetype[PDF - 377.35 KB]
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    Jan. 14, 2021
    Series:
    Scientific brief
    Description:
    Updated Jan. 14, 2021Information about the characteristics of these variants is rapidly emerging. Scientists are working to learn more about how easily they might spread, whether they could cause more severe illness, and whether currently authorized ...
    File Type:
    Filetype[PDF - 377.35 KB]
    Added:
    01/15/2021
  • Holiday celebrations and gatherings
    Filetype[PDF - 193.23 KB]
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    Jan. 14, 2021
    Description:
    Updated Jan. 14, 2021As cases, hospitalizations, and deaths continue to increase across the United States, the safest way to celebrate the winter holidays is to celebrate at home with people who live with you.Gatherings with family and friends who do...
    File Type:
    Filetype[PDF - 193.23 KB]
    Added:
    01/15/2021
  • US COVID-19 cases caused by variants
    Filetype[PDF - 399.92 KB]
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    Jan. 13, 2021
    Series:
    Scientific brief
    Description:
    Updated Jan. 13, 2021B.1.1.7 Lineage Cases in the United States*† Total Cases: 76*The cases identified above are based on a sampling of SARS-CoV-2-positive specimens and do not represent the total number of B.1.1.7 lineage cases that may be circula...
    File Type:
    Filetype[PDF - 399.92 KB]
    Added:
    01/15/2021
  • Testing and international air travel
    Filetype[PDF - 133.76 KB]
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    Jan. 13, 2021
    Description:
    Updated Jan. 13, 2021Air travel requires spending time in security lines and airport terminals, which can bring you in close contact with other people and frequently touched surfaces. Social distancing is difficult in busy airports and on crowded fli...
    File Type:
    Filetype[PDF - 133.76 KB]
    Added:
    01/15/2021
  • Travel : Frequently asked questions and answers
    Filetype[PDF - 165.48 KB]
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    Jan. 13, 2021
    Description:
    Updated Jan. 13, 2021
    File Type:
    Filetype[PDF - 165.48 KB]
    Added:
    01/15/2021
  • Crew disembarkations through commercial travel
    Filetype[PDF - 143.38 KB]
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    Jan. 12, 2021
    Description:
    Updated Jan. 12, 2021CDC is committed to helping cruise lines provide for the safety and well-being of their crew members while onboard cruise ships and as they disembark. CDC is allowing crew members to disembark from all cruise ships in U.S. waters...
    File Type:
    Filetype[PDF - 143.38 KB]
    Added:
    01/15/2021
  • Staffing resources : staffing resources and guidance
    Filetype[PDF - 801.47 KB]
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    Jan. 12, 2021
    Description:
    Updated Jan. 12, 2021These numbers reflect data from January 12, 2021 – number of staff can change daily.This map shows CDC deployments and CDC field staff. A total of 602 CDC staff are currently working in state, tribal, local, and territorial hea...
    File Type:
    Filetype[PDF - 801.47 KB]
    Added:
    01/15/2021
  • CDC expands negative COVID-19 test requirement to all air passengers entering the United States : : media statement : for immediate release: Tuesday, January 12, 2021
    Filetype[PDF - 69.23 KB]
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    January 12, 2021
    Description:
    The Centers for Disease Control and Prevention is expanding the requirement for a negative COVID-19 test to all air passengers entering the United States. Testing before and after travel is a critical layer to slow the introduction and spread of COVI...
    File Type:
    Filetype[PDF - 69.23 KB]
    Added:
    01/15/2021
  • Clinical laboratory COVID-19 response call : November 2, 2020
    Filetype[PDF - 2.05 MB]
    Personal Author:
    Chaitram, Jasmine
    Corporate Authors:
    Center for Surveillance, Epidemiology, and Laboratory Services (U.S.). Division of Laboratory Systems.
    Published Date:
    November 2, 2020
    Series:
    Clinical laboratory COVID-19 response call ; November 2, 2020
    Description:
    CDC’s Division of Laboratory Systems (DLS) convenes regular calls with clinical laboratories to discuss the nation’s clinical laboratory response to coronavirus disease (COVID-19). These Clinical Laboratory COVID-19 Response Calls take place ever...
    File Type:
    Filetype[PDF - 2.05 MB]
    Added:
    01/15/2021
  • Unsuitable underlying causes of death for assessing the quality of cause-of-death reporting
    Filetype[PDF - 587.75 KB]
    Personal Author:
    Flagg, Lee Anne; Anderson, Robert N.;
    Corporate Authors:
    National Center for Health Statistics (U.S.). Division of Vital Statistics.
    Published Date:
    January 11, 2021
    Series:
    National vital statistics reports ; v. 69, no. 14
    DHHS publication ; no. (PHS) 2020–1120
    Description:
    Objectives—This report expands the measures used to evaluate cause-of-death data quality by presenting a novel list of unsuitable underlying causes of death (UCOD). This list is intended to facilitate the measurement of the quality of cause-of- dea...
    File Type:
    Filetype[PDF - 587.75 KB]
    Added:
    01/15/2021
  • Clinical laboratory COVID-19 response call : December 28, 2020
    Filetype[PDF - 4.18 MB]
    Personal Author:
    Chaitram, Jasmine
    Corporate Authors:
    Center for Surveillance, Epidemiology, and Laboratory Services (U.S.). Division of Laboratory Systems.
    Published Date:
    December 28, 2020
    Series:
    Clinical laboratory COVID-19 response call ; December 28, 2020
    Description:
    CDC’s Division of Laboratory Systems (DLS) convenes regular calls with clinical laboratories to discuss the nation’s clinical laboratory response to coronavirus disease (COVID-19). These Clinical Laboratory COVID-19 Response Calls take place ever...
    File Type:
    Filetype[PDF - 4.18 MB]
    Added:
    01/15/2021
  • COVID-19 trends among persons aged 0–24 years — United States, March 1–December 12, 2020
    Filetype[PDF - 192.06 KB]
    Personal Author:
    Leidman, Eva; Duca, Lindsey M.; Omura, John D.; Proia, Krista; Stephens, P James W.; Sauber-Schatz, Erin K.;
    Corporate Authors:
    CDC COVID-19 Response Team.
    Published Date:
    January 13, 2021
    Series:
    MMWR. Morbidity and mortality weekly report ; v. 70, early release, January 13, 2021
    Description:
    What is already known about this topic? Studies have consistently shown that children, adolescents, and young adults are susceptible to SARS-CoV-2 infections. Children and adolescents have had lower incidence and fewer severe COVID-19 outcomes than a...
    File Type:
    Filetype[PDF - 192.06 KB]
    Added:
    01/15/2021
  • Clinical laboratory COVID-19 response call : October 19, 2020
    Filetype[PDF - 4.45 MB]
    Personal Author:
    Chaitram, Jasmine
    Corporate Authors:
    Center for Surveillance, Epidemiology, and Laboratory Services (U.S.). Division of Laboratory Systems.
    Published Date:
    October 19, 2020
    Series:
    Clinical laboratory COVID-19 response call ; October 19, 2020
    Description:
    CDC’s Division of Laboratory Systems (DLS) convenes regular calls with clinical laboratories to discuss the nation’s clinical laboratory response to coronavirus disease (COVID-19). These Clinical Laboratory COVID-19 Response Calls take place ever...
    File Type:
    Filetype[PDF - 4.45 MB]
    Added:
    01/15/2021
  • Viral hepatitis surveillance United States, 2018
    Filetype[PDF - 7.77 MB]
    Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Viral Hepatitis.. National Notifiable Diseases Surveillance System..
    Published Date:
    July 2020
    Description:
    Viral Hepatitis Surveillance — United States, 2018 is published by the Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC), U.S. Department of Health a...
    File Type:
    Filetype[PDF - 7.77 MB]
    Added:
    01/15/2021
  • MMWR. Morbidity and mortality weekly report, Vol. 70, no. 02, January 15, 2021
    Filetype[PDF - 729.74 KB]
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    01/15/2021
    Series:
    MMWR. Morbidity and mortality weekly report ; v. 70, no. 02
    File Type:
    Filetype[PDF - 729.74 KB]
    Added:
    01/14/2021
  • Use of Ebola Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020
    Filetype[PDF - 330.66 KB]
    Personal Author:
    Choi, Mary J.,; Cossaboom, Caitlin M.;; Whitesell, Amy N. ;; Dyal, Jonathan W. ;; Joyce, Allison;; Morgan, Rebecca L.;; Campos-Outcalt, Doug;; Person, Marissa;; Ervin, Elizabeth et al.;
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). United States. Advisory Committee on Immunization Practices..
    Published Date:
    01/08/2021
    Source:
    Recommendations and Reports / January 8, 2021 / 70(1);1–12
    Series:
    MMWR. Recommendations and reports: Morbidity and mortality weekly report. Recommendations and Reports / January 8, 2021 / 70(1);1–12
    Description:
    This report summarizes the recommendations of the Advisory Committee on Immunization Practices (ACIP) for use of the rVSVΔG-ZEBOV-GP Ebola vaccine (Ervebo) in the United States. The vaccine contains rice-derived recombinant human serum albumin and l...
    Status:
    current
    File Type:
    Filetype[PDF - 330.66 KB]